Purchase Order 75N91021P00749
- Not listed
- This is a $20,209.60 Firm Fixed Price Purchase Order awarded by the National Cancer Institute, an agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for a maintenance agreement with a performance period ending on July 11, 2025. This award does not utilize any set-aside designations. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific and has...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the maintenance of one genetic analyzer and one Arcturus XT system, with a potential value of $108,308.92. The period of performance is from August 1, 2018 to July 31, 2020. The place of performance is in Bethesda, Maryland. The contract does not have a...
- This is a $141,477.88 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Life Technologies Corporation, a for-profit manufacturer, for preventative maintenance services on a government-owned Life Technologies gene chip system. The contract does not utilize a set-aside. As a division of Thermo Fisher Scientific, Life Technologies provides specialized biotechnology products and services to support...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $338,622.71 firm-fixed price purchase order is for the acquisition of one Life Technologies GeneTitan Multi-Channel (MC) System. This specialized genetic analysis instrument will be used by the National Cancer Institute's Genitourinary Malignancies...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Human Genome Research Institute to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $14,862.96 contract is for laboratory equipment maintenance and repair services, including a 7G scanner, autoloader, FS450DX, and 7G workstation, with a performance period from July 1, 2024 to June 30, 2025....
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency of the U.S. government, to Life Technologies Corporation, a manufacturer of scientific instruments and reagents. The $20,500.00 contract is for the provision of preventative maintenance and repair services for the agency's laboratory DNA analyzer equipment, enabling the continued delivery of genotyping services. The contract has no set-aside designation. Life Technologies, which...
- This is a firm fixed price purchase order for a maintenance agreement on a genetic analyzer issued by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health. The contract, valued at $12,067.48, was awarded to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that supports biomedical research, applied markets, and forensic analysis for the federal government. Life...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $23,900.04 firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. The contract is for maintenance services to be performed between December 2023 and December 2024. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division. The award utilizes an existing Government-Wide Acquisition Contract vehicle and...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to Life Technologies Corporation, a for-profit manufacturer of scientific equipment, reagents, and consumables. The $32,586.40 contract provides genetic analyzers, reagents, assays, instruments, and associated repair services to support the NIH's healthcare, medical readiness, and biomedical research initiatives. The contract has a period of performance...
- This is a $16,500 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Life Technologies Corporation (a division of Thermo Fisher Scientific) for the base year of April 15, 2025 to April 14, 2026. The contract has two option years: $16,800 for April 15, 2026 to April 14, 2027, and $17,100 for April 15, 2027 to April 14, 2028. The contract is not set aside. Life Technologies, as a prime contractor, will provide the NIH Clinical Center with...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute to Life Technologies Corporation for $171,219.47 to provide annual preventive maintenance for a Life Technologies GeneAtitan 96 Genetic Analyzer. The contract has a performance period from August 2021 to August 2026 and does not utilize a set-aside designation. Life Technologies Corporation is the prime contractor and manufacturer of the genetic analysis equipment. The National Cancer Institute, which is part of the National Institutes of Health, funds this contract to support its biomedical research mission. The contract is one of several active Indefinite Delivery Vehicles that Life Technologies holds with federal agencies like the NIH, Department of the Interior, and Department of Veterans Affairs to provide ongoing maintenance and supplies for their specialized laboratory equipment and scientific instrumentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $35.2k | 8/16/24 | |
| P00002 | Exercise an Option | $34.2k | 8/21/23 | |
| P00001 | Exercise an Option | $33.2k | 7/7/22 | |
| Not listed | Not listed | $32.2k | 8/19/21 |